The molecular biomarkers that stand out as potential candidates for monitoring stroke prognosis include CRP, fibrinogen, IL-6 for the measurement of inflammation, NfL for neuroaxonal damage, and SOD activity for oxidative stress. This evidence concerns the gene NEFL and stroke disorder.